Director, Innovation – AI, IQVIA
Director, AI Solutions Delivery, IQVIA
Agentic AI will transform traditional clinical research processes as we know them today. The “agentification” of clinical trial workflows will be applied across startup, conduct and closeout to expedite trial activities, reduce white space, and improve quality. In this presentation, we will explore how agentic AI can augment activities across the R&D continuum, including site activation and start up activities and data review set up. Join us to learn how AI innovation is not just improving trial efficiency — it’s redefining what’s possible in clinical research.
Register now to learn how AI innovation is not just improving trial efficiency — it’s redefining what’s possible in clinical research.
Key takeaways:
For more information and to register, click here.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
